...
首页> 外文期刊>Pharmaceutical sciences. >Acute and Sub-Acute Oral Toxicity Evaluation of Astragalus hamosus Seedpod Ethanolic Extract in Wistar Rats
【24h】

Acute and Sub-Acute Oral Toxicity Evaluation of Astragalus hamosus Seedpod Ethanolic Extract in Wistar Rats

机译:Wistar大鼠黄芪种子荚果乙醇提取物的急性和亚急性口服毒性评估

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Oral consumption of Astragalus hamosus L. (AH) seedpod has been widely prescribed in traditional medicine system. However, its toxicity evaluation has never been investigated. Hence, the current study was performed to evaluate the toxicological profile of AH seedpod in acute and subacute assessments based on the OECD-guidelines 425 and 407 in male and female Wistar rats. Methods: In the acute study, ethanolic extract of AH at a single dose of 2000 mg/kg was orally administrated to six female rats. In the subacute assay, AH at the three different oral doses (75, 150 and 300 mg/kg) were administrated to both male and female rats for 28 consecutive days. Results: No death or behavioural changes were observed in the treated animals. In subacute test, in both sexes, no changes in organ weights observed. Biochemically, compared to the control, AH at the dose of 300 mg/kg slightly increased (p0.05) uric acid and creatinine and declined total cholesterol levels in both male and female rats. However, there is no statistically difference in other parameters such as albumin, triglyceride, blood urea, aspartate aminotransferase and alanine aminotransferase between AH treated groups and untreated controls. Hematologic parameters showed that AH at the maximum dose decreased red blood cells count only in male rats. Histopathological evaluation of liver and kidney exhibited no noticeable alterations in AH treated animals. Conclusion: It could be concluded that high excessive and long term consumption of AH may lead to renal dysfunction and deficiency in hematopoietic system.
机译:背景:传统医学系统已广泛规定口服黄芪种荚。但是,从未对其毒性评估进行过研究。因此,当前的研究是根据OECD指南425和407对雄性和雌性Wistar大鼠进行的急性和亚急性评估来评估AH种子荚的毒理学特征。方法:在急性研究中,对六只雌性大鼠口服单剂量2000 mg / kg的AH乙醇提取物。在亚急性测定中,连续28天对雄性和雌性大鼠施用三种不同口服剂量(75、150和300 mg / kg)的AH。结果:在治疗的动物中未观察到死亡或行为改变。在亚急性试验中,男女均未观察到器官重量的变化。生化方面,与对照组相比,雄性和雌性大鼠中300 mg / kg剂量的AH可使尿酸和肌酐略微升高(p <0.05),总胆固醇水平降低。但是,AH治疗组与未治疗对照组之间的其他参数(如白蛋白,甘油三酸酯,血尿素,天冬氨酸转氨酶和丙氨酸转氨酶)在统计上没有差异。血液学参数显示,最大剂量的AH仅在雄性大鼠中减少红细胞计数。肝脏和肾脏的组织病理学评估在AH治疗的动物中未显示出明显的变化。结论:可以得出结论,大量过量和长期服用AH可能导致肾功能障碍和造血系统缺陷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号